Chemours
546 hedge funds and large institutions have $6.78B invested in Chemours in 2018 Q1 according to their latest regulatory filings, with 81 funds opening new positions, 155 increasing their positions, 181 reducing their positions, and 67 closing their positions.
21% more first-time investments, than exits
New positions opened: 81 | Existing positions closed: 67
2% more funds holding
Funds holding: 537 → 546 (+9)
0.02% more ownership
Funds ownership: 76.72% → 76.75% (+0.02%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
5% less capital invested
Capital invested by funds: $7.11B → $6.78B (-$325M)
14% less repeat investments, than reductions
Existing positions increased: 155 | Existing positions reduced: 181
17% less call options, than puts
Call options by funds: $61.7M | Put options by funds: $73.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$227M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$115M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$80.4M |
| 4 |
First Eagle Investment Management
New York
|
+$58.2M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$49.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCIM
TIAA CREF Investment Management
New York
|
-$116M |
| 2 |
Renaissance Technologies
New York
|
-$98.8M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$70M |
| 4 |
Goldman Sachs
New York
|
-$58.2M |
| 5 |
GC
Greenlight Capital
New York
|
-$52.5M |
CC Hedge Fund Activity: Q1 2018 in Review
546 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q1 2018, worth a combined $6.78B — down 4.6% from $7.11B a quarter earlier.
Buyers outnumbered sellers: 81 funds opened new CC positions and 67 closed out — a net gain of 14 holders — while 155 added to existing stakes and 181 trimmed.
The largest buyer was Iridian Asset Management, opening a new position worth an estimated $227M. The largest seller was TIAA CREF Investment Management, cutting an estimated $116M.
- 546 institutional investors held Chemours (CC) as of Q1 2018, up from 537 in Q4 2017.
- Funds reported $6.78B of Chemours stock for Q1 2018, down 4.6% quarter-over-quarter.
- 81 funds opened new Chemours positions in Q1 2018 and 67 closed out, a net change of +14 holders.
- The largest Chemours buyer in Q1 2018 was Iridian Asset Management, an estimated $227M added.
- The largest Chemours seller in Q1 2018 was TIAA CREF Investment Management, an estimated $116M sold.
Based on aggregated 13F filings for Q1 2018.